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Selective crystallisation of carbamazepine
polymorphs on surfaces with differing properties†
Huaiyu Yang, Cai L. Song, Ying X. S. Lim, Wenqian Chen and Jerry Y. Y. Heng *
Surface-induced nucleation of carbamazepine (CBZ) in ethanol was investigated with different surface ma-
terials: glass, polytetrafluoroethylene (PTFE) and tin. The introduction of foreign surfaces with different
areas and surface chemistries into the solution has an impact on the crystal morphology and polymorphic
form (Form II or III). With an increase in supersaturation, a higher possibility of crystallisation of CBZ meta-
stable Form II was observed, as expected. Increasing the number of inserts resulted in a direct increase in
the surface area available for heterogeneous nucleation. The increase in surface area resulted in the greater
possibility of obtaining the metastable Form II of CBZ. The stable Form III preferred to nucleate on tin
rather than on glass and PTFE. The results indicate that the two different polymorphs of CBZ can be selec-
tively crystallised out from solution with the aid of a foreign surface. The kinetic mechanism of heteroge-
neous nucleation of the different polymorphs induced by foreign surfaces was discussed. The potential ap-
plications will be used to control and design the crystallisation process.
Introduction
Crystallisation is widely used as a purification technique for
active pharmaceutical ingredients (APIs) in the pharmaceuti-
cal industry.1 Different polymorphs of APIs may appear in a
crystallisation process. With different arrangements in the
crystal lattice, polymorphs have different physicochemical
properties such as solubility and melting point.2,3 These dif-
ferences directly affect the performance properties of the APIs
such as shelf life, efficacy and bioavailability.4 Polymorphic
purity is essential for quality control, as the presence of any
undesirable polymorphs or polymorphic transformation dur-
ing manufacturing processes induces substantial economic
loss (for example, more than $250 million loss due to an un-
known more stable form of ritonavir, an antiviral compound
for AIDS).5 The evaporation crystallisation processes of butyl
paraben in liquid–liquid phase separation are very different
on glass, metal and PTFE surfaces,6,7 and ibuprofen changes
morphology on Al, Au or self-assembled –CH3, –OH, and
–COOH monolayers.8 On a siloxane monolayer template, a
metastable polymorph of 1,3-bisĲm-nitrophenyl)urea
appeared.9 Porosity10 and roughness11 of surfaces also affect
the crystallization of proteins,11–14 glass15 and colloids.16 It is
important to understand the effect of surface properties on
the crystallisation from a process development perspective to
optimise the surfaces of crystallisers and to achieve better
control of the crystallisation process.
Carbamazepine (CBZ) is commonly used as an anticonvul-
sant and pain-relieving drug. Five anhydrous polymorphs of
CBZ were reported previously17 and only four forms (i.e. I, II,
III & IV) are commonly observed.18 Form III is thermodynam-
ically stable between ambient temperature and 70 °C,19 while
Forms I, II and IV are metastable but sometimes kinetically
favoured.20 It was reported previously that the degree of
supersaturation and the solvents determine the polymorph
outcome of CBZ.2,21 In this work, we focus on the effect of in-
troducing new foreign surfaces with differing properties, i.e.
different areas of the surfaces and different materials of
the surfaces, on the polymorph of CBZ. The study was
conducted at two different degrees of supersaturation in
cooling crystallisation in ethanol. The CBZ crystal struc-
ture, the interactions between surfaces and CBZ mole-
cules, and the pre-exponential factors in nucleation are
discussed.
Experimental
Materials
Carbamazepine (5H-dibenzazepine-5-carboxamide) was pur-
chased from Sigma Aldrich and AnalaR NORMAPUR® etha-
nol was purchased from VWR. Both chemicals were used as-
received. Micro-haematocrit capillary tubes from Jaytec Glass
Ltd (1.55 mm outer diameter), tin-coated wires (1.21 mm
outer diameter) and PTFE tubing (1.52 mm outer diameter)
were used. 40 mm of each material was placed in a 7 ml glass
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vial (moulded pathology media vials, Neutral Type 1B glass,
VWR International).
Crystallisation of carbamazepine
Solutions (3 ml) with CBZ concentrations of 40.0, 50.0, 60.0,
65.0 and 70.0 mg ml−1 in ethanol were prepared in glass
vials. Glass capillaries, PTFE tubes and tin wires were cut to
40 mm length and submerged (∼15 mm) in the CBZ/ethanol
solutions. The surface area of each vial in contact with the so-
lution was ∼950 mm2 (initial surface area), adding extra 5.9–
7.7% contact area (foreign surface area) for each insert (capil-
lary/tube/wire) submerged in the solution. 2 or 8 inserts with
random configurations were placed in the vials with the solu-
tion. The vials were sealed with caps and Parafilm on the out-
side to prevent evaporation of the solvent. The solutions were
heated up to 70 ± 1 °C for about one hour to ensure all the
solid CBZ dissolved and to minimise any history effect.22
Then, the solutions were cooled down to 20 °C in 30 minutes
inside a water bath controlled by a circulator (Grant LT). The
crystallisation process was recorded using a USB camera
(endoscope). For each condition, at least six experiments
were repeated; the shapes of all the crystals in the solution
were observed at about 3.5 hours after the solution tempera-
ture reached 20 °C. The number of experiments with the ap-
pearance of only needle crystals, prismatic crystals or both
needle and prismatic crystals in the whole solution (both on
the bottom of the vials and on the foreign surfaces) was com-
pared with the total number of parallel experiments
performed, and the percentage of occurrence of Form II (only
needle crystals observed), Form III (only prismatic crystals
observed) and both Forms II and III (both needle and pris-
matic crystals observed) was determined.
Results and discussion
Only two different morphologies (prismatic and needle-
shaped crystals, i.e. Forms III and II, respectively) were ob-
served in this work. The CBZ crystals of needle and prismatic
shapes were Forms II and III, respectively, as confirmed by
XRPD (Fig. 1). As Form III is a stable polymorph, there is no
transition from Form III to Form II, which is consistent with
the observation in experiments. Form III seeds were added to
the ethanol solution, but no Form II crystals were formed un-
der the range of experimental conditions in this work. It is
reported that Form II will transform to Form III under stir-
ring conditions,23,24 but in this work, the needle-shaped crys-
tals did not change shape after 5 weeks, indicating no obvi-
ous transition from Form II to Form III without stirring. At
20 °C, the solubility of Form III in ethanol is 18.60 mg ml−1
and the difference in solubility between Form II and Form III
at the temperature range T = 20–60 °C is almost constant.13
The solubility of Form II is 1.1 times (average) higher than
the solubility of Form III in the temperature range between
10 °C and 30 °C.13 The supersaturation in this work is calcu-
lated based on the solubility of Form III.
When the supersaturation was 2.15, no Form II crystals
were obtained in the experiments. With the increase in super-
saturation (S), the possibility of Form II formation increases
from <7% at S = 2.69 to 100% at S = 3.76, as shown in Fig. 2.
The supersaturation determines the polymorphs in the nucle-
ation of CBZ, as higher supersaturation usually leads to meta-
stable polymorphs, which is consistent with Ostwald's rule
and as observed for several other systems. For L-histidine,25
eflucimibe,26 L-glutamic acid,27 carbamazepine,2,28
m-hydroxybenzoic acid and o-aminobenzoic acid,29 the meta-
stable polymorph nucleated at high supersaturation, and the
stable polymorph at low supersaturation.
When foreign surfaces were introduced to the solutions,
the percentage of polymorph outcome dramatically changed.
Fig. 3 shows one case where Form II of CBZ nucleated and
grew on the surface of glass capillaries and PTFE tubes,
whereas Form III nucleated and grew on the surface of tin
Fig. 1 XRPD patterns for needle-shaped crystals (Form II with green
colour) and prismatic shaped crystals (Form III with blue colour) of
CBZ.
Fig. 2 The occurrence of CBZ polymorphic forms as a function of the
degree of supersaturation in glass vials for crystallisation at T = 20 °C
after 3.5 hours. Form II occurrence in green, Form III in blue and the
mixture of Forms II and III in blue/green.
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wire. In Fig. 3(a) and (b), the crystals on the bottom were
Form II, the same as the crystals on the foreign surfaces, but
the crystals in the solution in Fig. 3(c) were Form III. The for-
eign surface influences the nucleation at the solid–liquid
interface, but may also influence the nucleation process in
the bulk solution. In all the experiments shown in Fig. 4–7,
at least several crystals were observed on both the foreign
surface and the bottom of the vials. Therefore, there are three
possibilities: 1 and 2: only prismatic or needle-shaped crys-
tals on both foreign surfaces and the bottom of the vial, re-
spectively, and 3: at least several prismatic and needle-
shaped crystals on foreign surfaces or the bottom of the vial.
Fig. 4 shows that when 2 inserts of glass, PTFE or tin were
brought into contact with the solution at S = 2.69 (Form III),
the percentage of obtaining only Form III crystals dramati-
cally decreased to <33% for all three materials. If 8 inserts (4
times larger foreign surface area) were in contact with the so-
lution, the possibility of crystallising only Form III decreased
to <17% for all three surfaces. With the same increase in
area of the foreign surfaces, the possibility of obtaining only
Form III increased in the order of materials of glass < PTFE
< tin. The surface energy of glass,30 PTFE,31 and tin32 is 310,
19, and 709 mJ m−2, respectively.
It is noted that the trends in the polymorph (Form III
only) occurrence for these three surfaces are opposite be-
tween the low supersaturation (S = 2.69) and the high super-
saturation (S = 3.49). However, a direct link between the sur-
face properties of these inserts and the polymorphic outcome
is unclear. There is a competition between kinetics and ther-
modynamics33 on the polymorphic outcome, as also shown in
our previous work on template-induced and solvent-induced
polymorphic occurrence domains (TiPOD/SinPOD).12,13,34 The
polymorphic outcome is affected by crystallisation conditions
including concentration, the supersaturation range, tempera-
ture, solvent, the presence of additives, nucleating surfaces
and several other external factors.35,36 In this work, glass and
PTFE surfaces, which have lower surface energies than tin in
this work, induced a high percentage of occurrence of Form
II, which is consistent with the literature that the cyano sur-
face induces more Form II than mercapto and fluoro surfaces,
which have more than two times higher surface energy than
the cyano surface.13 It is noticed that when 2 or 8 inserts of
tin were added, if both Form II and Form III crystals were ob-
served in the solution, nearly all the crystals on the tin sur-
faces would be Form III in the experiments, which indicates
Fig. 3 Crystal formation at S = 2.69 on the surface of (a) glass, (b)
PTFE and (c) tin inserts.
Fig. 4 The occurrence of CBZ polymorphic forms as a function of the
number of inserts at S = 2.69 after 3.5 hours. Form II occurrence in
green, Form III in blue and the mixture of Forms II and III in blue/
green.
Fig. 5 The occurrence of CBZ polymorphic forms as a function of the
number of inserts at S = 3.49 after 3.5 hours. Form II occurrence in
green, Form III in blue and the mixture of Forms II and III in blue/green.
Fig. 6 The occurrence of CBZ Form III only (the crystals are only
Form III with no Form II present, on either the inserts or the bottom of
the vials) as a function of the number of inserts (2 or 8 inserts) at S =
3.49 and 2.69.
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that, unlike glass and PTFE surfaces, tin surfaces prefer to
generate Form III carbamazepine.
Fig. 5 shows that when the supersaturation was 3.49, intro-
ducing 2 inserts of foreign surfaces reduced the percentage of
obtaining only Form III for the PTFE and tin surfaces, but a
similar percentage for the glass surface. With 8 inserts in con-
tact with the solution, the possibility of obtaining only Form
III obviously decreased for all three surfaces. With tin surfaces
in the solution, it was observed that Form III crystallised on
the tin surfaces while Form II crystallised on the bottom in
most of the experiments when Form II and Form III were ob-
served simultaneously in one experiment. This is consistent
with the experimental results at low supersaturation (Fig. 4)
that the tin surface attracts Form III crystals.
Fig. 6 shows that an increase in the number of foreign
surfaces leads to a decrease in the percentage of Form III
appearing (without any appearance of Form II) with all three
material surfaces at two supersaturations. The foreign sur-
faces have a larger influence, i.e. a larger decrease of the poly-
morph occurrence percentage with an increase in area, for all
cases except the glass inserts at higher supersaturation. The
variation of obtaining only Form III with 2 inserts is much
higher than the variation with 8 inserts (shown in the ESI†).
The larger foreign surface area results in smaller differences
between two supersaturations or different materials.
Fig. 4 and 5 show that at the same supersaturation, the in-
fluence of changing the surface properties (glass, PTFE and
tin with more than 3 times differences) on polymorph ap-
pearance was greater than that of adding foreign surface
areas (2 and 8 inserts with 2–3 times differences). Fig. 6
shows that when similar foreign surface areas with the same
surface properties were introduced in the solution, the influ-
ence of higher supersaturation (less than 2 times difference)
was greater than the influence of lower supersaturation (less
than 1.5 times difference). The overall influence of the super-
saturation ratio (2.69 and 3.49) was smaller than the influ-
ence of adding foreign surface areas (2 and 8 inserts). Based
on the calculation from eqn (1), we can estimate the differ-
ences among polymorph occurrences at each supersaturation
(S), surface area (A) or surface property (P) (shown in the
ESI†). The influences of these three parameters are in the or-
der: P (50% difference) > A (35% difference) > S (18% differ-
ence) in the range of this experimental work.
(1)
Fig. 7 shows the percentage of occurrence of at least one
Form III crystal in the solution, which equals to the sum of
the percentages of occurrence of only Form III crystals
(shown in Fig. 6) and the percentage of occurrence of both
Form II and Form III in the solution. Fig. 7 shows that the
increase in the area of foreign surfaces leads to a decrease
in the percentage of Form III outcome for the glass and
PTFE surfaces. However, for the tin surfaces, there is no ob-
vious trend at both low and high supersaturations with the
increase in surface area. It is noticed that for most of the
cases, in which Form II and Form III appear in one experi-
ment, the crystals on the tin surface are Form III and the
Form II crystals are located on the bottom of the vials. The
results indicate that tin prefers to capture/hook polymorph
Form III rather than Form II. This is consistent with the ex-
perimental results that if PTFE and tin inserts were intro-
duced in the solution at the same time, Form III crystals
preferably nucleated and grew on the tin surfaces, while
Form II crystals always appeared on the PTFE surfaces, as
shown in Fig. 8.
Form II has a crystal unit cell volume of 5.72 nm3,37
whereas Form III has a relatively very small cell volume of
1.17 nm3,38 which is more than 4 times smaller than that of
Form II. The H-bond distance, –O⋯NH, calculated with Mer-
cury software is 2.890 Å and 2.929 Å for Forms II and III, re-
spectively, indicating a stronger H-bond in Form II than in
Form III. Two typical groups of Form II and Form III CBZ
Fig. 7 The occurrence of CBZ Form III and both Forms II and III (only
for the case where no pure Form II is present on either the inserts or
the bottom of the vials) as a function of the number of inserts (2 or
8 inserts) at S = 3.49 and 2.69.
Fig. 8 Both PTFE and tin surfaces were inserted into a
carbamazepine–ethanol solution at S = 3.49. Form II crystallised on the
PTFE surface whilst Form III crystallised on the tin surface.
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molecules in a unit cell are shown in Fig. 9; the two groups
of Form II stand parallel shoulder to shoulder, and the two
groups of Form III are connected in a head-to-tail manner
where the two close molecules look like they are embedded
to each other. The crystal unit cells in Fig. 9 show that the
H-bonds in Form III have only two directions which are
nearly vertical to each other, and the H-bonds in Form III
have eight different directions. If some CBZ molecules are
attracted to the foreign surface, the stronger H-bonds of
Form II and the higher possibility to attract other molecules
from several directions may help to capture other CBZ mole-
cules. The molecule in Form III has only one or two direction
options to capture other CBZ molecules. The influence of the
weaker H-bond between two CBZ molecules and the limited
H-bond directions may make it more difficult to crystallise
than Form II in heterogeneous nucleation on the foreign sur-
faces. CBZ molecules should have stronger interactions with
glass (–OH) and PTFE (–F) surfaces than with tin surfaces,
due to the weak H-bond between CBZ and –OH or –F, which
may be the reason why Form II is favourable on glass and
PTFE than on tin. This is consistent with the literature that
the stronger H-bonds between CBZ and other molecules (sol-
vents) hinder the stabilization of the interactions in the self-
association of Form III before nucleation.21
Many experiments have shown that heterogeneous nucle-
ation is more likely to occur at higher supersaturation, while
homogeneous nucleation tends to occur at lower supersatura-
tion.2,12,13,25,28 According to the classical nucleation theory
(eqn (2)), this decrease in free energy results in a higher nu-
cleation rate:
(2)
where J is the nucleation rate, k is the Boltzmann constant,
T is temperature, ΔGc is the critical energy of nucleation,
and A is the pre-exponential factor. The higher the nucleation
rate of one polymorph is, the higher the percentage of occur-
rence of this polymorph form will be. In this study, one can
envisage several routes for the nucleation of Forms II and III,
for example:
1. Form II and Form III are both nucleated by homoge-
neous nucleation (in the bulk solution).
2. Form II and Form III are nucleated by homogeneous
and heterogeneous nucleation, respectively. An increase in
the surface area will affect the heterogeneous nucleation, and
there should be no influence on the homogeneous nucleation
of Form II. These first and second routes are not consistent
with the experimental results reported here.
3. Forms II and III are nucleated by heterogeneous and
homogeneous nucleation, respectively.
The pre-exponential factor, A in eqn (2), is proportional
to the nuclei centre, which in homogeneous nucleation is
one cluster molecule and in heterogeneous nucleation is a
number of foreign particles. With a foreign surface where
the heterogeneous nucleation occurs, if the foreign surface
area increases, the pre-exponential factor of the heteroge-
neous nucleation of Form II will also increase. Compared
with the heterogeneous nucleation of Form II, the homoge-
neous nucleation rate of Form III should remain the same
and, therefore, the percentage of occurrence of the poly-
morph decreases. However, in most experiments with the
tin surface, where both forms of CBZ appear, Form III
crystallised on the tin surface and Form II crystals were lo-
cated on the bottom of the vials. If homogeneous nucle-
ation of Form III happens, the nuclei formed in the solu-
tion will settle on the bottom too which cannot transform
to Form II, which is not consistent with the experimental
observation.
4. Form II and Form III are both from heterogeneous
nucleation.
An increase in the foreign surface area leads to an in-
crease in the pre-exponential factor and nucleation rate of
the heterogeneous nucleation of Form II. At the same time,
the heterogeneous nucleation rate of Form III should also in-
crease, but experimental results show a decrease in the possi-
bility of Form III formation, indicating that the nucleation
rate of Form III increases to a lesser extent than that of
Form II. Comparing the values of the heterogeneous pre-
exponential factors of Form II and Form III is very compli-
cated. The kinetics is dependent on many factors, such as
temperature, molecular mobility, etc.,39,40 but the nucleation
process and kinetics are still not fully understood. The as-
sumption that heterogeneous nucleation occurs for both
Form II and Form III in the solution with foreign surfaces is
most probable. However, without accurate induction time for
each polymorph in the solution, it is very difficult to under-
stand the process. These nucleation processes need to be fur-
ther investigated by determining the thermodynamic and ki-
netic parameters of heterogeneous nucleation and analysing
the relationship between the solute and the solvent or solute
with foreign surfaces.
Fig. 9 Crystalline molecular structures of Form II (a and c) and Form
III (b and d).
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Conclusions
Crystallisation experiments involving carbamazepine in etha-
nol were performed in glass vials with and without foreign sur-
faces, glass, PTFE or tin. Higher supersaturation and larger for-
eign surface areas both result in a higher percentage of
unstable Form II and a lower percentage of stable Form III for-
mation. In the range of the experimental conditions, the influ-
ence on the polymorph is in the order: foreign surface proper-
ties > foreign surface areas > degrees of supersaturation.
Form III was found to nucleate more preferentially on the
surface of tin than those of PTFE and glass in the same solu-
tion. The percentage of obtaining Form III on the tin surface
remained the same with the increase in surface area at equal
supersaturation. A means of selectively crystallising two poly-
morphs of carbamazepine based on the surface properties is
presented.
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